Study of VX-770 and Rifampin in Healthy Male Subjects

NCT01018368 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: VX-770
DRUG: Rifampin

Sponsor

Vertex Pharmaceuticals Incorporated